The reason could be that targeting FKBP and Pin1 is more complicated due to their essential and heterogenous functions in different tissues such as in neurons and cancer cells, complex network of interacting proteins and pathways being affected, and inhibitors not being specific to the isoform. Here, PIN1 is linked to cancer.